JPRN-UMIN000002152已完成1 期
A phase 1 study of combination therapy with gemcitabine and candesartan in patients with pancreatic cancer - GECA-1 study
niversity of Tokyo, Department of Gastroenterology0 个研究点目标入组 24 人开始时间: 2009年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with systolic blood pressure < 100mmHg 2) Patients with an active concomitant infection 3) Patients with digestive ulcer or gastrointestinal bleeding 4) Patients with severe heart or renal disease 5) Patients with an active pulmonary fibrosis or interstitial pneumonia 6) Patients with a previous history of a severe drug hypersensitivity 7) Patients with an active concomitant malignancy 8) Pregnant, lactating female and patients of reproductive potential who did not use effective contraception 9) Patients with hypertension 10) Patients who received ACE or ARB 11) Patients with uncontrollable massive pleural effusion or massive ascites 12) Inappropriate patients for entry on this study in the judgement of the investigator
研究者
相似试验
已完成
1 期
A phase 1 study of combination therapy with gemcitabine S-1 and leucovorin in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000007556The University of Tokyo, Department of Gastroenterology18
已完成
2 期
A phase 2 study of combination therapy with gemcitabine and candesartan in patients with advanced or recurrent pancreatic cancerpancreatic cancerJPRN-UMIN000005580niversity of Tokyo, Department of Gastroenterology33
已完成
2 期
A phase 2 study of combination therapy with gemcitabine S-1 and leucovorin in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000010720The University of Tokyo Hospital49
已完成
2 期
A phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable gallbladder cancer.unresectable gallbladder cancerJPRN-UMIN000002824Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine30
已完成
2 期
A Phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable pancreatic cancer.unresectable pancreatic cancerJPRN-UMIN000001221Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine18